Insmed | INSM - Cost Of Sales

Name: Insmed | INSM - Cost Of Sales
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Insmed,INSM,Cost,Of,Sales,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Insmed

Insmed reported $13.83M in Cost of Sales for its fiscal quarter ending in March of 2023.

	Cost Of Sales		Date
Alimera Sciences ALIM:US	USD 2.03M	97K	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 126.55M	741K	Mar/2023
Dynavax Technologies DVAX:US	USD 14.71M	62.78M	Mar/2023
Gilead Sciences GILD:US	USD 1.4B	5M	Mar/2023
Heron Therapeutics HRTX:US	USD 16.85M	4.23M	Mar/2023
Insmed INSM:US	USD 13.83M	761K	Mar/2023
Mirati Therapeutics MRTX:US	817K	217K	Mar/2023
Novartis NVS:US	USD 3.83B	8M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 457.5M	83.1M	Mar/2023
Sarepta Therapeutics SRPT:US	USD 35.02M	4.22M	Mar/2023
Seattle Genetics SGEN:US	USD 111.78M	3.57M	Mar/2023
Ultragenyx Pharmaceutical RARE:US	USD 12.26M	6.94M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 266.9M	16.4M	Mar/2023